HSRx Biopharmaceutical has announced that HSRx 431, the company’s broad-spectrum antiviral drug candidate that is administered orally, has shown that it is effective against the Zika virus. Read More »
Sangamo BioSciences Inc. recently announced that SB-FIX has been granted orphan drug designation by the U.S. Food and Drug Administration (FDA). Read More »
Avara Pharmaceuticals Services Inc. recently announced that it has come to terms on an agreement for the acquisition of a manufacturing facility from AstraZeneca located in Avlon, Avonmouth, England. Read More »
Oasima Pharmaceutical AB has announced that Fredrik Gynnerstedt has been appointed the company’s new CFO. Read More »
PharmRight and Zipit work together to help patients manage complicated medication regimes. Read More »
Array BioPharma announced last week that its New Drug Application (NDA) for binimetinib has been accepted by the U.S. Food and Drug Administration (FDA). Read More »
Amgen and Servier last week announced that their cardiovascular collaboration has seen an advancement due to Servier deciding to exercise its option for the commercialization of omecamtiv mecarbil in Europe for chronic heart failure. Read More »
Available in wide range of fluorochromes for research use only. Read More »
Laboratorios Salvat S.A.and Arbor Pharmaceuticals LLC recently partnered on the launch of OTOVEL (ciprofloxacin 0.3% and fluocinolone acetonide 0.025%) otic solution. Read More »
Vifor Pharma, which is owned by Galenica, will be combined with Relypsa to form an important cardio-renal care provider in the United States. Read More »
The decision by the FDA was done under accelerated approval with continued approval dependent on consequent trials verifying the clinical benefit of BLINCYTO. Read More »
If drug manufacturers ever wonder whether they have a collective image problem, the answer is yes, according to a recent Gallup poll. Read More »
The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to Catalyst Pharmaceuticals Inc. for Firdapse to treat myasthenia gravis (MG).e Read More »
Mylan NV yesterday announced that its inter-parties review (IPR) proceeding in regard to U.S. Patent No. 8,969,302, which is owned by Yeda Research & Development Co. and licensed to Teva Pharmaceuticals, was ruled in its favor of by the U.S. Patent and Trademark Office (PTO) and found unpatentable. Read More »
The Journal of Community and Supportive Oncology recently published a study that presented two key research findings dealing with treatment options for breast cancer. Read More »
Taiho Ventures today announced that it has invested in Arcus Biosciences, a groundbreaking immuno-oncology company that develops small molecules and antibodies to combine with agents to form its own internal combinations. Read More »
Patent-protected Alzheimer's medication subject of infringement litigation. Read More »
Agreement gives Amgen global development and commercial rights to BI 836908 (AMG 420). Read More »
Voters concerned about health topics, especially affordability and accessibility and Medicare. Read More »
Adding Prolia to glucocorticoid therapy increases bone mineral density. Read More »
Alerts Sign-up
